Drugs / DA-9501
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01438931 Comparator | Jul 2011 → Feb 2012 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-9501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01438931 ↗ |
| Known as | Dexmedetomidine | “The purpose of this study is to evaluate the efficacy and the safety of DA-9501 (Dexmedetomidine) in sedation during the surgery or medical procedure without intubation under...” NCT01438931 ↗ |